
Upcoming Live Events
There are currently no live events.
Past Live Events
Thu 5:00 PM EDT
Improving ILD Diagnosis in a Multidisciplinary Discussion Team Incorporating a Genomic Classifier
Thu 6:30 PM EDT
Disease State Awareness: Explore the Clinical Implications of Uncontrolled Type 2 Inflammation in Asthma and COPD
Tue 7:30 PM EDT
REPLACE: (Riociguat rEplacing PDE5i therapy evaLuated Against Continued PDE5i therapy): A Look at Phase IV Study Data
Tue 6:30 PM EDT
Dual Inhibition: Targeting Systemic and Localized Type 2 Inflammation in Asthma.
Learn the importance of identifying systemic and localized Type 2 inflammation in your patients with moderate-to-severe, uncontrolled asthma. In this event, an expert...
Thu 6:30 PM EDT
An in-depth review of the PATENT-1 PAH-CTD subgroup data
Thu 6:30 PM EST
Expanding Access within the Bronch Suite: Benefits of Adding Navigated TTNA to Your Bronchoscopy
Mon 12:00 PM EST
12/5/22 - Considerations in the management of patients with CTPEH (WHO Group 4).
Wed 12:00 PM EST
11/30/22 - TEZSPIRE® (tezepelumab-ekko): A Clinical Overview
Please join Amgen and AstraZeneca as they share a different approach that may shift your point of view. Our expert will cover the efficacy and safety data and how it...
Wed 12:00 PM EDT
10/26/2022 - Understanding the Role of OFEV® (nintedanib) capsules
Please join Steven Nathan, MD, FCCP, as he discusses the current state of OFEV, including recent guideline updates. Dr. Nathan will discuss the safety and efficacy of...
Wed 6:30 PM EDT
Targeting Eosinophilic Disease in the Unified Airway Treating Severe Eosinophilic Asthma or Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With a Biologic
This webinar will cover clinical trial data and the latest real-world evidence for treating severe eosinophilic asthma with a targeted biologic treatment.
Wed 6:30 PM EDT
TEZSPIRE® (tezepelumab-ekko): A Clinical Overview
Please join Amgen and AstraZeneca as they share a different approach that may shift your point of view.
Wed 6:30 PM EDT
Improving Yields for Better Patient Outcomes with 4D Navigation
Will discuss combining multiple procedures (EBUS-TBNA, Navigated Peripheral Bronchoscopy, and Navigated-Percutaneous Biopsy) into one in a single care setting within...
Wed 6:30 PM EDT
Adempas for PAH-CHD
Adempas for Pulmonary Arterial Hypertension associated with Congenital Heart Disease: Data from Patent-1 subgroup
Wed 6:30 PM EDT
Integrating the Envisia Genomic Classifier to Improve ILD Diagnostic & Prognostic Confidence
This session will discuss key considerations for the diagnosis of patients with Interstitial Lung Disease (ILD) and provide a review on how to incorporate the Envisia...
Mon 12:00 PM EDT
A Deep Dive into the "I"s of Non-cystic fibrosis bronchiectasis
Experts in non-cystic fibrosis bronchiectasis (NCFB) will discuss current challenges in diagnosis and management, characterization of disease severity, and emerging...
Mon 12:00 PM EDT
REPLACE: (Riociguat rEplacing PDE5i therapy evaLuated Against Continued PDE5i thErapy): A Look at Phase IV Study Data
This virtual learning session will review the clinical data from a recent Phase IV study.
Wed 6:30 PM EDT
May 4, 2022
Mon 12:00 PM EDT
Recognizing Chronic Fibrosing Interstitial Lung Disease with a Progressive Phenotype
This presentation will provide an overview of chronic fibrosing interstitial lung diseases (ILDs), with a focus on those with progressive phenotypes. Expert faculty...
Mon 12:00 PM EDT
Understanding and diagnosing eosinophilic granulomatosis with polyangiitis (EGPA)
In this programme, divided into four segments, viewers will learn about the pathophysiology, diagnosis, clinical complications associated with EGPA, and...
Mon 12:00 PM EST
Nasal High Flow for Hypoxemic and Hypercapnic patients
Mon 12:00 PM EST
REPLACE: (Riociguat rEplacing PDE5i therapy evaluated Against Continued PDE5i therapy): A Look at Phase IV Study Data
This virtual learning session will review the clinical data from a recent Phase IV study. This program is sponsored by Bayer Healthcare.
Tue 6:30 PM EST
Efficient, intelligent, and personalized remote patient monitoring for COPD: How to ensure your patients get the right care at the right time.
This webinar provides an overview of a Remote Patient Monitoring solution developed by Dr. Gerald Criner and colleagues at Temple University to efficiently monitor and...
Mon 12:00 PM EST
REPLACE: (Riociguat rEplacing PDE-5i therapy evaLuated Against Continued PDE-5i thErapy): A Look at Phase IV Study Data**
This virtual learning session will review the clinical data from a recent Phase IV study.
Mon 12:00 PM EST
Understanding the Role TSLP Plays Across Several Asthma Patients: Interactive Case Discussion Webinar
There’s a new way to think about asthma, and it starts at the top of the inflammatory cascade. Join us 12/6/21 at 12pm ET for an interactive, case-based discussion...
Tue 6:30 PM EST
Managing COVID-19 in Hospitalized Patients: Current Treatment Landscape-Nov. 30, 2021
Wed 6:30 PM EST
Advances in Single-Use Bronchoscopy Across Sites of Care
Please join Dr. Fariborz Rezai as he discusses the advancements of single-use bronchoscopy and their clinical application across various patient profiles and sites of...
Mon 12:00 PM EST
Prone Positioning: What’s New?
This program will provide a comprehensive look at proning including the latest evidence and practical applications of proning patients on various levels of respiratory...
Mon 12:00 PM EDT
REPLACE: (Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy): A Look at Phase IV Study Data
This virtual learning session will review the clinical data from a recent Phase IV study.
Wed 6:30 PM EDT
Managing COVID-19 in Hospitalized Patients: Current Treatment Landscape
Dr. Goldman will provide an overview of the current treatment landscape for patients who have been hospitalized with COVID-19 as recommended by the NIH COVID-19...
Wed 6:30 PM EDT
Nontuberculous Mycobacterial Lung Disease (NTM-LD): Individualizing Treatment Goals and Strategies – An Innovative Whiteboard View
This activity will explore evidence-based strategies for the diagnosis, evaluation, and treatment of NTM-LD and help clinicians individualize treatment selection and...
Tue 6:30 PM EDT
TSLP in Asthma: Examining the Evidence*
There’s a new way to think about asthma and it starts at the top of the inflammatory cascade. Join us on October 12th at 6:30 p.m. as two experts explore the role of a...
Wed 6:30 PM EDT
Evidence for Using a Biologic to Treat Two Different Eosinophil-Driven Diseases: Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
This program will review safety and efficacy data supporting the use of a biologic as a treatment for patients with severe eosinophilic asthma or CRSwNP.
Wed 6:30 PM EDT
Exploring the Role of OFEV® (nintedanib) capsules
Join Dr. Tanzira Zaman from Cedars-Sinai Medical Center in Los Angeles, CA, as she reviews background information followed by an overview of the OFEV pivotal safety...
Tue 6:30 PM EDT
THE ROLE OF ENHANCED PATHOGEN DETECTION IN THE MANAGEMENT OF SEPTIC PNEUMONIA PATIENTS
The clinical use of multiplex PCR platforms, like the BioFire® FilmArray® Pneumonia (PN) Panel, in CAP patients dramatically increases the frequency of detection of...
Wed 6:30 PM EDT
REPLACE: (Riociguat rEplacing PDE5i therapy evaluated Against Continued PDE5i therapy): A Look at Phase IV Study Data
This virtual learning session will review the clinical data from a recent Phase IV study.
Wed 6:30 PM EDT
Unclassifiable Interstitial Lung Disease: Update on Challenges and Successes *
In this Webinar, the faculty will review the signs, symptoms, laboratory, histopathologic, and image findings that lead to better diagnosis of uILD, review their...
Mon 12:00 PM EDT
Evidence-based use of HFNC: The development of Clinical Practice Guidelines
The webinar will review the the ESICM Clinical Practice Guidelines (Rochwerg, 2020) recently published in Intensive Care Medicine, regarding the use of Nasal High Flow...
Mon 12:00 PM EDT
“Eosinophils in Health and Disease”
This will be a pre-recorded video with Professor Howarth narrating the slide deck and providing insight/context to the data. After the video has been played, he will...
Wed 6:30 PM EDT
Demystifying robotic technologies
Hear Dr. Janani Reisenauer, Dr. Ganesh Krishna and Dr. Sebastian Fernandez-Bussy examine how to demystify new robotic technologies. While reviewing patient cases, they...
Wed 6:30 PM EDT
Diving deeper on your sleep apnea diagnosis: Why differentiating central vs obstructive apnea is crucial to establishing the treatment plan
With the arrival of new sleep apnea treatment options, differentiating CSA vs OSA is crucial to establishing the treatment plan. Phrenic nerve stimulation, hypoglossal...
Tue 6:30 PM EDT
Unclassifiable Interstitial Lung Disease: Update on Challenges and Successes
In this Webinar, the faculty will review the signs, symptoms, laboratory, histopathologic, and image findings that lead to better diagnosis of uILD, review their...
Wed 6:30 PM EDT
The Intensivists’ Gastrostomy
Learn about PUG: the next advancement in the shift to bedside procedural care. Join us for a discussion of ultrasound gastrostomy, current practice, and experience...
Wed 2:00 PM EDT
Data Driven Approaches to Identify Progression and Optimise Outcomes in Interstitial Lung Disease
Respiratory specialists around the world are now adapting to virtual models of care for their patients. These models offer significant opportunities for data driven...
Mon 12:00 PM EDT
Percepta Nasal Swab: A Novel Genomic Test to Provide Objective Clarity in Early Lung Cancer Risk Assessment
The current landscape of lung nodule assessment can benefit from more objective tools in determining the risk of malignancy. The Percepta Nasal Swab is a novel genomic...
Mon 12:00 PM EDT
Why Aren’t You Using Nasal High Flow?
An interdisciplinary look at the implementation of Nasal High Flow across the hospital setting to improve patient flow, reduce escalation, and preserve ICU beds.
Wed 6:30 PM EDT
Update on Sotatercept from the Phase 2 Clinical Program: A Potential Therapy Targeting the Underlying Cause of PAH
Join us for a presentation focused on an investigational therapy that may rebalance BMPR-II/activin receptor signaling.
Mon 12:00 PM EDT
Consider Giving Your Patients What They Prefer: How Should Patient Preferences Inform Inhaler Decisions in COPD?
Boehringer Ingelheim is pleased to bring you a stimulating discussion featuring experts, Donald Mahler, MD and Jill Ohar, MD.
Mon 12:00 PM EDT
COVID-19: From Early Treatment to Inpatient Management
This Innovation Theatre is intended to educate attendees on the current management of COVID-19 patients in the outpatient and critical care setting. Attendees will...
Wed 6:30 PM EDT
The Role of OFEV® (nintedanib) capsules: A Treatment Journey
Join Dr. Shambhu Aryal as he reviews background information followed by an overview of the OFEV pivotal safety and efficacy data. This presentation is made on behalf...
Wed 6:30 PM EDT
REPLACE: (Riociguat rEplacing PDE5i therapy evaluated Against Continued PDE5i therapy): A Look at Phase IV Study Data
Wed 6:30 PM EDT
Recognizing Uncontrolled Asthma Is Only the First Step
A goal of asthma treatment is to achieve and maintain asthma control. However, uncontrolled asthma remains common and often goes unrecognized by patients and...
Tue 6:30 PM EDT
Impact of Robotic-Assisted Bronchoscopy
MONARCH® Platform Programs In An Academic & Community Setting. Drs. D. Kyle Hogarth and Susan Garwood share their firsthand experience using MONARCH®, the first...
Wed 6:30 PM EDT
Disrupting the Lung Cancer Care Continuum with Novel Genomic Tests from Diagnosis to Treatment Management
Speakers will discuss the gaps in the lung cancer diagnosis and care continuum and the transformative role of novel genomic tests, such as a non-invasive nasal swab...
Wed 6:30 PM EDT
Recognizing Chronic Fibrosing Interstitial Lung Disease and The Impact of COVID-19 on Clinical Care
This presentation will provide an overview of chronic fibrosing interstitial lung diseases (ILDs), with a focus on those with progressive phenotypes. Expert faculty...
Wed 6:30 PM EDT
TSLP in Asthma: Examining the Evidence
There’s a new way to think about asthma and it starts at the top of the inflammatory cascade. Join us as two experts explore the role of a key epithelial cytokine,...
Mon 12:00 PM EST
Clinical Evidence for the Selection of Triple Therapy for the Management of Adults With Asthma or COPD
Join Dr. Nathanael Brady as he explores recent clinical evidence supporting the use of triple therapy for the maintenance treatment of adult patients with Asthma or...
Wed 6:30 PM EST
Functional Lung Imaging: Translational Medicine and Clinical Applications
Understanding of the determinants of ventilation defects and ventilation heterogeneity may lead to more efficacious treatments for acute and chronic lungs diseases and...
Wed 3:30 PM PST
What Was Old Is New Again. A Novel, More Bioavailable Antifungal
Join Shyam Subramanian, MD FCCP, on February 17, 2021 at 6:30 pm as he discusses the diagnosis and management of systemic fungal infections and shares how advanced...
Mon 9:00 AM PST
Nasal High Flow Before, During, and After COVID-19. What Comes Next?
This webinar will explore the mechanism of action of Nasal High Flow and the clinical evidence for use before and during the COVID-19 pandemic. Evidence for the use of...
Wed 6:30 PM EST
The COVID-19 Pandemic and A Treatment Approach for Hospitalized Patients
This program will cover the epidemiology of the current COVID-19 pandemic and show where demographic disparities exist. Information on the clinical trials, efficacy...
Mon 6:30 PM EST
Underlying Inflammatory Mechanisms: Nasal Polyposis and Airway Comorbidities
An informative, non-CME, virtual disease state presentation focusing on nasal polyposis and airway comorbidities. This presentation will familiarize viewers with the...
Tue 6:30 PM EST
Interstitial Lung Diseases: An Overview of Progression and Radiological Features
Join Drs. Gregory Cosgrove and Jonathan Chung as they discuss the HRCT features and patterns associated with a progressive phenotype in patients with chronic fibrosing...
Mon 6:30 PM EST
REPLACE (Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy): A look at Phase IV Study Data
This virtual learning session will review the clinical data from a recent Phase IV study looking at a treatment paradigm in the management of adult patients with PAH
Wed 6:30 PM EST
A Potential Therapy for Rebalancing BMPR2: A New Direction in PAH
Join us for a presentation focused on a new potential therapy that may change the course of PAH progression by rebalancing BMPR2 signaling.
Mon 6:30 PM EST
Hot Topics in ILD Diagnosis: MDD, Genomics and PF ILD
This interactive session covers the key elements of an MDD, the role of the Envisia genomic classifier, and the identification of progressive fibrosing ILD.
Tue 6:30 PM EST
Recognizing Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype
This program will provide an overview on chronic fibrosing interstitial lung diseases (ILDs), with specific examples of those with progressive phenotypes. Expert...
Thu 6:30 PM EDT
The Role of Eosinophils and Their Potential Heterogeneity in Airway Disease
Eosinophils are increasingly being recognized as important in the pathophysiology of various airway diseases and an important cell type in disease endotypes. This...
Fri 12:00 PM EDT
Nebulization in the COVID-19 Era: Evidence-Based Review
Nebulization safety in the COVID-19 era has been challenged due to concerns regarding transmissibility of the virus via nebulizer. Join International expert Rajiv...
Thu 6:30 PM EDT
A Path to Asthma Control
A Path to Asthma Control: DUPIXENT® (dupilumab) Is the Only Biologic Indicated for OCS-Dependent Asthma
Tue 6:30 PM EDT
A Brief Review of Clinical and Real-World Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma
This expert-led event will include a review and discussion of clinical and real-world data evaluating a biologic treatment to help reduce exacerbations and maintenance...
Thu 6:30 PM EDT
Management of Adults With Asthma or COPD With Inhaled Maintenance Treatment Options
Are you up to date on the newest developments in Asthma and COPD maintenance treatment options? Join Dr. Ravi Kalhan review the latest clinical evidence supporting the...
Tue 6:30 PM EDT
Sounding the Alarm: The Role of TSLP Across the Spectrum of Asthma Inflammation
There’s a new way to think about asthma and it starts at the top of the inflammatory cascade. Join us as an expert explores the role of a key epithelial cytokine,...
Tue 12:00 PM EDT
COPD Management in the time of COVID-19 & New Real World Data on Inhaler Choice
Has COVID-19 impacted the way you treat your COPD patients?
Thu 6:30 PM EDT
The Current State of OFEV® (nintedanib): A Treatment Journey
The program will review background information followed by the most up-to-date data supporting the efficacy and safety of OFEV. The presentation is sponsored by...
Thu 6:30 PM EDT
ACCURACY IS EVERYTHING: RECENT CLINICAL EVIDENCE IN NAVIGATION
A static image can make nodule biopsies using lung navigation challenging. You need confidence throughout the procedure to know you are on target. Learn about the...
Tue 6:30 PM EDT
Chronic Rhinosinusitis With Nasal Polyps: From Pathophysiology to Management
An informative, non-CME, disease state virtual presentation focusing on chronic rhinosinusitis with nasal polyps (CRSwNP).
Tue 6:30 PM EDT
A New Direction in PAH: A Potential Therapy for Rebalancing BMPR2 Signaling
Join us for a presentation focused on a new potential therapy that may change the course of PAH progression by rebalancing BMPR2 signaling.
Tue 6:30 PM EDT
Treatable traits approach towards COPD management for busy pulmonologists
With the GOLD 2020 strategy document, the focus on utilization of the treatable traits approach of symptoms and exacerbations for COPD management continues to gain...
Thu 4:00 PM EDT
Best Practices in Remote Patient Monitoring for the Respiratory Specialist
Respiratory Specialists are now rapidly adapting their models of care in light of COVID-19. What are the best practices for remote monitoring of respiratory patients?...